Thu, 25 Feb 2010 14:51:17 -0500 PeerView Neurology CME/CNE/CPE Video Podcast PVI, PeerView Institute for Medical Education http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. en-us 2007 PeerView Press,24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://media.peerviewpress.com/000136/podcast/pvi/xml/VidNeurologyCME-CNE-CPE_144.jpg PeerView Neurology CME/CNE/CPE Video Podcast http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Neurology no Rhonda R. Voskuhl, MD - Optimizing Treatment to Delay Disease Progression and Preserve Cognitive Function: A Review of Established and Emerging Therapies for MS PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PPVNE06053r82.m4v Thu, 25 Feb 2010 14:43:48 -0500 Science & Medicine no 00:19:13 MS, multiple sclerosis, cognitive dysfunction, disease-modifying agents, RRMS, cladribine, interferon, modafinil CME/CNE/CPE Information - Optimizing Treatment to Delay Disease Progression and Preserve Cognitive Function: A Review of Established and Emerging Therapies for MS PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06053CMEinfo.pdf Thu, 25 Feb 2010 14:43:25 -0500 Science & Medicine no 00:00:00 MS, multiple sclerosis, cognitive dysfunction, disease-modifying agents, RRMS, cladribine, interferon, modafinil Rachelle S. Doody, MD, PhD - Exploring the Potential of Novel Mechanisms in the Treatment of Alzheimer's and Huntington's Diseases PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PPVNE06214r76.m4v Wed, 17 Feb 2010 14:31:00 -0500 Science & Medicine no 00:21:09 Alzheimer's; Alzheimer's disease; Huntington's disease, Huntington's; neurodegenerative CME/CNE/CPE Information - Exploring the Potential of Novel Mechanisms in the Treatment of Alzheimer's and Huntington's Diseases PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06214CMEinfo.pdf Wed, 17 Feb 2010 14:30:57 -0500 Science & Medicine no 00:00:00 Alzheimer's; Alzheimer's disease; Huntington's disease, Huntington's; neurodegenerative Michael J. Gitlin, MD - Differentiating Bipolar Disorder From Major Depressive Disorder: A Case-Based Approach to Improving Diagnosis and Treatment in Primary Care PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PPVNE06108p13_2.m4v Wed, 23 Dec 2009 16:17:29 -0500 Science, Medicine no 00:29:52 bipolar disorder, major depressive disorder, mood disorder, borderline personality disorder, depression CME/CNE/CPE Information - Differentiating Bipolar Disorder From Major Depressive Disorder: A Case-Based Approach to Improving Diagnosis and Treatment in Primary Care PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE06108CMEinfo_2.pdf Wed, 23 Dec 2009 16:17:02 -0500 Science, Medicine no 00:00:00 bipolar disorder, major depressive disorder, mood disorder, borderline personality disorder, depression Timothy Vollmer, MD - Selecting Immunomodulating Therapy in Relapsing-Remitting Multiple Sclerosis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. This 2-part, case-based activity focuses on several practical aspects of the management of relapsing-remitting multiple sclerosis. Highlights from the first case scenario include risk stratification for conversion to MS in patients who present with clinically isolated syndrome, as well as treatment selection for first-line therapy in the RRMS population. The second case study emphasizes the management of patients who are nonresponsive to first-line immunomodulating therapy. The potential role of emerging therapies for the treatment of this disease is also summarized. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PA04911FCp11.m4v Thu, 01 Oct 2009 14:33:51 -0400 Science, Medicine no 00:34:55 multiple sclerosis, MS, relapsing-remitting multiple sclerosis, RRMS, immunomodulating therapy CME/CNE/CPE Information - Selecting Immunomodulating Therapy in Relapsing-Remitting Multiple Sclerosis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA04911FCCMEinfo.pdf Thu, 01 Oct 2009 14:33:48 -0400 Science, Medicine no 00:00:00 multiple sclerosis, MS, relapsing-remitting multiple sclerosis, RRMS, immunomodulating therapy Martin R. Farlow, MD - Scientific and Clinical Frontiers in the Treatment of Alzheimer’s Disease: Identification of Novel Pathways and Development of New Treatments PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. This 2-part activity focuses on some of the pathological and clinical aspects related to regional cerebral hypometabolism in patients with Alzheimer’s disease. Part 1 includes a brief discussion of key concepts of the underlying pathophysiology of Alzheimer’s disease and a review of the aspects of cerebral hypometabolism, including genetic polymorphisms, hypothesized pathological mechanisms, and potential treatments. The second part of the activity summarizes recent clinical data related to potential treatments to improve cognitive function in Alzheimer’s disease by overcoming cerebral hypometabolism. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PPVNE05944r65.m4v Tue, 15 Sep 2009 14:26:36 -0400 Science, Medicine no 00:21:56 Alzheimer's; Alzheimer's disease; dementia; Alzheimer's treatments; Alzheimer's medications CME/CNE/CPE Information - Scientific and Clinical Frontiers in the Treatment of Alzheimer’s Disease: Identification of Novel Pathways and Development of New Treatments PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05944CMEinfo.pdf Tue, 15 Sep 2009 14:26:33 -0400 Science, Medicine no 00:00:00 Alzheimer's; Alzheimer's disease; dementia; Alzheimer's treatments; Alzheimer's medications Henry S. Friedman, MD - Assessing the Safety and Efficacy of Emerging Therapies in Newly Diagnosed and Recurring Glioblastoma Multiforme: Latest Results From Orlando PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts discuss the latest clinical trial data on targeted and other new therapies for glioblastoma multiforme, assess the clinical implications of these data, and review some of the key ongoing studies that clinicians and patients should be aware of. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PPVNE05931s554.m4v Fri, 24 Jul 2009 14:45:54 -0400 Science, Medicine no 00:18:00 glioblastoma multiforme, GBM, bevacizumab, temozolomide, radiation, VEGF inhibitor, mTOR, irinotecan, antiangiogenic, immunostimulation CME/CNE/CPE Information - Assessing the Safety and Efficacy of Emerging Therapies in Newly Diagnosed and Recurring Glioblastoma Multiforme: Latest Results From Orlando PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PPVNE05931CMEinfo.pdf Fri, 24 Jul 2009 14:45:35 -0400 Science, Medicine no 00:00:00 glioblastoma multiforme, GBM, bevacizumab, temozolomide, radiation, VEGF inhibitor, mTOR, irinotecan, antiangiogenic, immunostimulation Stuart J. Connolly, MD, FRCPC - The Evolving Role of Antiplatelet Therapy for Atrial Fibrillation: Highlights From the ACC Scientific Sessions 2009 PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in management of stroke prevention in patients with atrial fibrillation discuss challenges and controversies with the current standard of care for stroke prevention and analyze emerging options for stroke prevention. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PI04851FC_s551.m4v Tue, 16 Jun 2009 14:16:43 -0400 Science, Medicine no 00:27:44 atrial fibrillation, stroke, stroke prevention, antiplatelet therapy, anticoagulation, vitamin K antagonists CME/CNE/CPE Information - The Evolving Role of Antiplatelet Therapy for Atrial Fibrillation: Highlights From the ACC Scientific Sessions 2009 PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PI04851FCCMEinfo.pdf Tue, 16 Jun 2009 14:16:41 -0400 Science, Medicine no 00:00:00 atrial fibrillation, stroke, stroke prevention, antiplatelet therapy, anticoagulation, vitamin K antagonists Scott H. Kollins, PhD, MS - Insights on Adult ADHD: Recognition, Diagnosis, and Treatment PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. In this activity, experts in the management of adult ADHD discuss the challenges in diagnosing and treating ADHD in adults. http://media.peerviewpress.com/000136/podcast/pvi/m4v/PA03852FCr421.m4v Fri, 20 Mar 2009 15:07:25 -0400 Science, Medicine no 00:47:45 Attention-deficit/hyperactivity disorder, ADHD, impulsivity, hyperactivity, anxiety, depression, substance abuse, stimulant therapy, nonstimulant therapy, cognitive-behavioral therapy CME/CNE/CPE Information - Insights on Adult ADHD: Recognition, Diagnosis, and Treatment PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. http://media.peerviewpress.com/000136/podcast/pvi/pdf/PA03852FCCMEinfo.pdf Fri, 20 Mar 2009 15:07:11 -0400 Science, Medicine no 00:00:00 Attention-deficit/hyperactivity disorder, ADHD, impulsivity, hyperactivity, anxiety, depression, substance abuse, stimulant therapy, nonstimulant therapy, cognitive-behavioral therapy